Healthtech Summit selects Medopad as a Top 20 Digital Health Company in Europe
Medopad has been selected as a top 20 Digital Health company in Europe at the Healthtech Summit - Tech Tour. This is the second year running Medopad has received this accolade.
Medopad was selected from hundreds of applicants and nominations to present to a group of prestigious international investors, venture capitalists, corporate partners and business angels at the SwissTech Convention Centre and Biopôle in Lausanne, Switzerland.
Pierre Chauvineau, Vice President of Boston Scientific and President of Healthtech Summit mentioned: “This year’s Summit is happening at a time when many insiders are commenting that digital health is at an ‘inflection point’. Healthcare is finally embracing digital health solutions in the mainstream and it is likely that the winners and losers of tomorrow will be decided around these concepts.”
A dedicated committee of leading international investors, senior business leaders and healthcare representatives conducted a rigorous review process to identify the 20 companies. Companies were judged on the uniqueness of their technology, the strength of their business model, vision, capability to execute on their business plan, and the quality and track record of their management.
Read about our latest news and achievements.
Johns Hopkins University to Leverage Medopad’s Patient Monitoring Platform and AI Capabilities to Develop New Clinical and Health Innovations
Johns Hopkins University has signed a memorandum of understanding with Medopad to explore new projects using its patient monitoring platform, Artificial Intelligence and Machine Learning capabilities. As part of the University’s Global mHealth Initiative and Technology Innovation Center, the two organisations will also develop joint clinical and public health projects and innovations that leverage Medopad’s technology and expertise.Read More
Healthtech Summit selects Medopad as a Top 20 Digital Health Company in EuropeRead More